Mylan foresees potential coronavirus impact on finances
Mylan CEO sees potential hit in the company’s finances due to the coronavirus outbreak as the organization prepares for the launch of Viatris.
Archives for March 2, 2020
FDA reports first drug shortage due to coronavirus outbreak
The US FDA announces shortage of a drug due to a site affected by coronavirus, as it focuses on the protection of the supply chain from outbreak impacts.
Rare disease trials create common burdens
In time for Rare Disease Day, orphan-disease patients, site managers and service providers discuss challenges obstacles faced in trial participation.
Elligo initiatives promote patient population diversity
The company’s Goes Direct effort seeks to partner with local doctors and other community healthcare providers to encourage broader representation in clinical trials.
Clinical Ink expands data access on eSource platform
The company has added an eConsent component to its eSource solution to facilitate better data access and sharing.
Mallinckrodt offers up generics business for bankruptcy in $1.6bn opioid deal
As part of its efforts to reach a global settlement to resolve opioid claims, Mallinckrodt will file for Chapter 11 bankruptcy for its specialty generics subsidiary.